Current primary open-angle glaucoma treatments and future directions

References

• MonemiSSpaethGDaSilvaAIdentification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1Hum Mol Genet200514672573315677485
   PubMed Web of Science ®Google Scholar
• TamuraHKawakamiHKanamotoTHigh frequency of open-angle glaucoma in Japanese patients with Alzheimer’s diseaseJ Neurol Sci20062461–2798316564058
   PubMed Web of Science ®Google Scholar
• VyasPNaikUGangaiahJBEfficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360 degrees synechial angle-closure glaucoma: a preliminary studyIndian J Ophthalmol2011591131621157066
   PubMed Web of Science ®Google Scholar
• NEI Glaucoma and Optic Neuropathies Program [Web page]Bethesda, MDNational Eye Institute2009 [updated 2009]. Available from: http://www.nei.nih.gov/strategicplanning/nationalplan1.pdfAccessed March 3, 2011
   Google Scholar
• DipiroJTalbertRLYeeGCWellsBGPoseyLMPharmacotherapy: A Pathophysiologic Approach7th edNew York, NYMcGraw Hill2009
   Google Scholar
• HeitingGHaddrillMGlaucoma: Types, Symptoms, Diagnosis and Treatment [updated Dec, 2011] Available from: http://www.allaboutvision.com/conditions/glaucoma.htm#typesofglaucomaAccessed June 6, 2012
   Google Scholar
• ParkBCTibudanMSamaraweeraMShenXYueBYInteraction between two glaucoma genes, optineurin and myocilinGenes Cells200712896997917663725
   PubMed Web of Science ®Google Scholar
• MuschDCGillespieBWNiziolLMCashwellLFLichterPRFactors associated with intraocular pressure before and during 9 years of treatment in the Collaborative Initial Glaucoma Treatment StudyOphthalmology2008115692793317964655
   PubMed Web of Science ®Google Scholar
• HeijlALeskeMCBengtssonBHymanLHusseinMReduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol2002120101268127912365904
   PubMed Web of Science ®Google Scholar
• AAOAmerican Academy of Ophthalmology Glaucoma Panel, Primary Open Angle Glaucoma. [Web page]San Francisco, CAAAO PPP Glaucoma Panel, Hoskins Center for Quality Eye Care2010 Available from: http://www.aao.org/pppAccessed March 3, 2011
   Google Scholar
• LichterPRMuschDCGillespieBWGuireKEJanzNKWrenPAInterim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgeryOphthalmology2001108111943195311713061
   PubMed Web of Science ®Google Scholar
• KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol2002120670171312049574
   PubMed Web of Science ®Google Scholar
• SommerATielschJMKatzJRelationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye SurveyArch Ophthalmol19911098109010951867550
   PubMed Web of Science ®Google Scholar
• GogatePDeshpandeRChelerkarVDeshpandeSDeshpandeMIs glaucoma blindness a disease of deprivation and ignorance? A case-control study for late presentation of glaucoma in IndiaIndian J Ophthalmol2011591293521157069
   PubMed Web of Science ®Google Scholar
• BayerAUKellerONFerrariFMaagKPAssociation of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer’s disease and Parkinson’s diseaseAm J Ophthalmol2002133113513711755850
   PubMed Web of Science ®Google Scholar
• BayerAUFerrariFErbCHigh occurrence rate of glaucoma among patients with Alzheimer’s diseaseEur Neurol200247316516811914555
   PubMed Web of Science ®Google Scholar
• GRFGlaucoma Research Foundation. [Website]San FranciscoGlaucoma Research Foundation [updated May 1, 2009]; Available from: http://www.glaucoma.org/learn/diagnostic_test.phpAccessed February 25, 2011
   Google Scholar
• NarayanaswamyANeogABaskaranMA randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertensionIndian J Ophthalmol200755212713117322603
   PubMedGoogle Scholar
• KatzungBGBasic and Clinical Pharmacology7th edNorwalk, CTAppleton and Lange1997
   Google Scholar
• FranksWARenardJPCunliffeIARojanapongpunPA 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertensionClin Ther200628333233916750448
   PubMed Web of Science ®Google Scholar
• BlondeauPRousseauJAAllergic reactions to brimonidine in patients treated for glaucomaCan J Ophthalmol2002371212611865954
   PubMed Web of Science ®Google Scholar
• KerrCRHassIDranceSMWaltersMBSchulzerMCardiovascular effects of epinephrine and dipivalyl epinephrine applied topically to the eye in patients with glaucomaBr J Ophthalmol19826621091147037047
   PubMed Web of Science ®Google Scholar
• DiggoryPCassels-BrownAVailAHillmanJSRandomised, controlled trial of spirometric changes in elderly people receiving timolol or betaxolol as initial treatment for glaucomaBr J Ophthalmol19988221461499613379
   PubMed Web of Science ®Google Scholar
• SchumanJSEffects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2Ophthalmology200010761171117710857839
   PubMed Web of Science ®Google Scholar
• ClinicalPharmacologyDrug Monographs. [Web database]: Clinical Pharmacology; [updated 2009–2010] Available from: http://www.clinicalpharmacology-ip.com/default.aspxAccessed March 3, 2011
   Google Scholar
• MicromedexDrug Monograph. [Web database]: Micromedex; [updated 2011] Available from: http://www.thomsonhc.comAccessed March 3, 2011
   Google Scholar
• KammerJAKatzmanBAckermanSLHollanderDAEfficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre studyBr J Ophthalmol2010941747919726422
   PubMed Web of Science ®Google Scholar
• DenisPBaudouinCBronAFirst-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressureBMC Ophthalmol201010420181282
   PubMed Web of Science ®Google Scholar
• AngAReddyMAShepstoneLBroadwayDCLong term effect of latanoprost on intraocular pressure in normal tension glaucomaBr J Ophthalmol200488563063415090413
   PubMed Web of Science ®Google Scholar
• StankiewiczAWierzbowskaJSiemiatkowskaAThe additive effect of dorzolamide hydrochloride (Trusopt) and a morning dose of bimatoprost (Lumigan) on intraocular pressure and retrobulbar blood flow in patients with primary open-angle glaucomaBr J Ophthalmol201094101307131120558428
   PubMed Web of Science ®Google Scholar
• MansbergerSLHughesBAGordonMOcomparison of initial intraocular pressure response with topical β-adrenergic antagonists and prostaglandin analogues in African American and White individuals in the Ocular Hypertension Treatment StudyArch Ophthalmol2007125445445917420364
   PubMedGoogle Scholar
• WatsonPGBarnettMFParkerVHaybittleJA 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucomaBr J Ophthalmol200185896296811466256
   PubMed Web of Science ®Google Scholar
• RobinALOcular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpineTrans Am Ophthalmol Soc19969489101 discussion 101–1038981691
   PubMedGoogle Scholar
• SuzukiYIwaseAAraieMRisk factors for open-angle glaucoma in a Japanese population: the Tajimi StudyOphthalmology200611391613161716828504
   PubMed Web of Science ®Google Scholar
• MitchellPHourihanFSandbachJWangJJThe relationship between glaucoma and myopia: the Blue Mountains Eye StudyOphthalmology1999106102010201510519600
   PubMed Web of Science ®Google Scholar
• HigginbothamEJOlanderKWKimEEGrundenJWKwokKKTresslerCSFixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked studyArch Ophthalmol2010128216517220142538
   PubMedGoogle Scholar
• SellemERoulandJFBaudouinCPredictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combinationBMC Ophthalmol2010101020346127
   PubMed Web of Science ®Google Scholar
• MartinezASanchez-SalorioMA comparison of the long-term effects of dorzolamide 2% and brinzolamide 1%, each added to timolol 0.5%, on retrobulbar hemodynamics and intraocular pressure in open-angle glaucoma patientsJ Ocul Pharmacol Ther200925323924819348600
   PubMed Web of Science ®Google Scholar
• NakamotoKYasudaNEffect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucomaJ Glaucoma200716435235717570997
   PubMed Web of Science ®Google Scholar
• Kimal AriciMTopalkaraAGulerCAdditive effect of latanoprost and dorzolamide in patients with elevated intraocular pressureInt Ophthalmol1998221374210090447
   PubMed Web of Science ®Google Scholar
• MaruyamaKShiratoSAdditive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trialJ Glaucoma200615434134516865013
   PubMed Web of Science ®Google Scholar
• HigginbothamEJSchumanJSGoldbergIOne-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertensionArch Ophthalmol2002120101286129312365906
   PubMed Web of Science ®Google Scholar
• RheeDJPeaceJHMallickSLandryTABergaminiMVA study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertensionClin Ophthalmol20082231331919668722
   PubMedGoogle Scholar
• DoiLMMeloLAJrPrataJAJrEffects of the combination of bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomised clinical trialBr J Ophthalmol200589554754915834081
   PubMed Web of Science ®Google Scholar
• DaplingRBCunliffeIALongstaffSInfluence of apraclonidine and pilocarpine alone and in combination on post laser trabeculoplasty pressure riseBr J Ophthalmol199478130327906539
   PubMed Web of Science ®Google Scholar
• ParrishRKFeuerWJSchiffmanJCLichterPRMuschDCFive-year follow-up optic disc findings of the Collaborative Initial Glaucoma Treatment StudyAm J Ophthalmol20091474717724e71119152871
   PubMed Web of Science ®Google Scholar
• CheungWGuoLCordeiroMFNeuroprotection in glaucoma: drug-based approachesOptom Vis Sci200885640641618521010
   PubMed Web of Science ®Google Scholar
• SteigerwaltRDGianniBPaoloMBombardelliEBurkiCSchonlauFEffects of Mirtogenol on ocular blood flow and intraocular hypertension in asymptomatic subjectsMol Vis2008141288129218618008
   PubMed Web of Science ®Google Scholar
• HeYLeungKWZhangYHMitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: protection by antioxidantsInvest Ophthalmol Vis Sci20084941447145818385062
   PubMed Web of Science ®Google Scholar
• University of Roma La SapienzaRetinal nerve fibres layers thickness study in glaucomatous patientsClinicalTrialsgov [website on the Internet]Bethesda, MDUS National Library of Medicine2010 [updated December 3, 2010]. Available from: http://clinicaltrials.gov/ct2/show/NCT01254006?term=NCT01254006&rank=1. NLM identifier: NCT01254006Accessed March 3, 2011
   Google Scholar
• Future Products ManagementTreatment of glaucomatous neuropathy with food additivesClinicalTrialsgov [website on the Internet]Bethesda, MDUS National Library of Medicine2005 [updated March 10, 2009]. Available from: http://clinicaltrials.gov/ct2/show/NCT00196677?term=NCT00196677&rank=1. NLM identifier: NCT00196677Accessed March 3, 2011
   Google Scholar
• Sooft ItaliaEffects of the oral administration of an association of forskolin with rutin and vitamins B on intraocular pressure in patients affected by primary open angle glaucoma and treated with either beta-blockers or prostaglandin eye dropsClinicalTrialsgov [website on the Internet]Bethesda, MDUS National Library of Medicine2009 [updated June 5, 2012]. Available from: http://clinicaltrials.gov/ct2/show/NCT00863811?term=NCT00863811.&rank=1. NLM identifier: NCT00863811Accessed March 30, 2011
   Google Scholar
• ZhongLBradleyJSchubertWErythropoietin promotes survival of retinal ganglion cells in DBA/2 J glaucoma miceInvest Ophthalmol Vis Sci20074831212121817325165
   PubMed Web of Science ®Google Scholar
• ZhanGLCamrasCBPalmbergPFTorisCBEffects of marijuana on aqueous humor dynamics in a glaucoma patientJ Glaucoma200514217517715741823
   PubMed Web of Science ®Google Scholar
• TomidaIAzuara-BlancoAHouseHFlintMPertweeRGRobsonPJEffect of sublingual application of cannabinoids on intraocular pressure: a pilot studyJ Glaucoma200615534935316988594
   PubMed Web of Science ®Google Scholar
• FangJHWangXHXuZRJiangFGNeuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damageBMC Neurosci2010113120199668
   PubMed Web of Science ®Google Scholar
• VorwerkCKLiptonSAZurakowskiDHymanBTSabelBADreyerEBChronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantineInvest Ophthalmol Vis Sci1996378161816248675405
   PubMed Web of Science ®Google Scholar
• DreyerEBZurakowskiDSchumerRAPodosSMLiptonSAElevated glutamate levels in the vitreous body of humans and monkeys with glaucomaArch Ophthalmol199611432993058600890
   PubMed Web of Science ®Google Scholar
• YucelYHGuptaNZhangQMizisinAPKalichmanMWWeinrebRNMemantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucomaArch Ophthalmol2006124221722516476892
   PubMedGoogle Scholar
• OsborneNNRecent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandonedActa Ophthalmol200987445045419141144
   PubMed Web of Science ®Google Scholar
• KoMLPengPHHsuSYChenCFDietary deficiency of vitamin E aggravates retinal ganglion cell death in experimental glaucoma of ratsC Eye R2010359842849
   PubMed Web of Science ®Google Scholar
• RohYJMoonCKimSYParkMHBaeYCChunMHGlutathione depletion induces differential apoptosis in cells of mouse retina, in vivoNeurosci Lett2007417326627017400377
   PubMed Web of Science ®Google Scholar
• The Catholic University of KoreaEvaluation of systemic glutathione level in patients with normal tension glaucomaClinicalTrials gov [website on the Internet]Bethesda, MDUS National Library of Medicine2007 [updated June 14, 2010]. Available from: http://clinicaltrials.gov/ct2/show/NCT00570362?term=NCT00570362&rank=1. NLM identifier: NCT00570362Accessed March 3, 2011
   Google Scholar
• LukschARainerGKoyuncuDEffect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucomaBr J Ophthalmol2005891212515615740
   PubMed Web of Science ®Google Scholar
• PiltzJRBoseSLanchoneyDThe effect of nimodipine, a centrally active calcium antagonist, on visual function and mascular blood flow in patients with normal-tension glaucoma and control subjectsJ Glaucoma1998753363429786563
   PubMed Web of Science ®Google Scholar
• HarrisAEvansDWCantorLBMartinBHemodynamic and visual function effects of oral nifedipine in patients with normal-tension glaucomaAm J Ophthalmol199712432963029439355
   PubMed Web of Science ®Google Scholar
• CelliniMPossatiGLCaramazzaNProfazioVCaramazzaRThe use of flunarizine in the management of low-tension glaucoma: a color Doppler studyActa Ophthalmol Scand Suppl199722457589589742
   PubMedGoogle Scholar